Y
cbdMD, Inc.
YCBDCIK 0001644903NYSENon-AcceleratedSmaller ReportingPerfumes, Cosmetics & Other Toilet PreparationsNorth CarolinaFY ends Sep 30
Period
FY 2025
Revenue
$19.19M
Net Income
$-2.04M
Total Assets
$10.42M
Equity
$7.23M
Shares Out
10.50M
Op. Cash Flow
$-1.45M
Business
cbdMD, Inc. is a consumer wellness company focused on developing, manufacturing, marketing and selling supplement brands powered by natural compounds. Its products include hemp-derived cannabinoids (broad- and full-spectrum CBD), hemp-derived Delta-9 THC where permitted, oils, gummies, capsules, soft-gels, topicals, ready-to-drink beverages, nootropic and functional mushroom formulations, and pet tinctures, chews and topicals. The company operates multiple brands and platforms, including cbdMD®, Paw CBD®, ATRX® and Herbal Oasis, and maintains manufacturing, R&D and quality programs. Products are sold via direct-to-consumer e-commerce, online marketplaces, wholesale distribution to national and regional retailers, specialty health and pet channels, beverage distributors and emerging international markets.
Summary from filing dated 2025-12-19
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 | FY 2021 2021-09-30 |
|---|---|---|---|---|---|---|
| Gross Sales | 19 | 20 | 25 | 37 | 47 | |
| Allowances | −210 | −440,152 | −898,495 | −2 | −3 | |
| Total Net Sales | 19 | 19 | 24 | 35 | 44 | |
| Cost of sales | 7 | 7 | 9 | 13 | 14 | |
| Gross Profit | 12 | 12 | 15 | 22 | 30 | |
| Operating expenses | 14 | 15 | 24 | 40 | 50 | |
| Loss from operations | −2 | −3 | −22 | −78 | −20 | |
| Decrease of contingent liability | 0 | 74,580 | 185,638 | 8 | −7 | |
| Increase in fair value of convertible debt | 87,380 | −429,789 | 0 | — | — | |
| Interest income (expense) | 34,308 | −29,507 | 63,702 | 16,246 | −28,930 | |
| Loss before provision for income taxes | −2 | −4 | −23 | −70 | −24 | |
| Benefit (expense) for income taxes | 0 | 0 | 0 | 0 | 895,000 | |
| Net Loss | −2 | −4 | −23 | −70 | −23 | |
| Preferred dividends | 2 | 4 | 4 | 4 | 3 | |
| Net Loss attributable to common shareholders | −4 | −8 | −27 | −74 | −26 | |
| Basic and Diluted earnings per share (in dollars per share) | −1.09 | −14.29 | −13.32 | −55.8 | −0.47 | |
| Weighted average number of shares Basic and Diluted: (in shares) | 4 | 539,069 | 2 | 1 | 55 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2024 2024-06-30 | FY 2024 2024-03-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 2 | 2 | — | — | — | |
| Accounts receivable, net | 1 | 983,910 | — | — | — | |
| Inventory, net | 3 | 2 | — | — | — | |
| Inventory prepaid | 214,795 | 159,006 | — | — | — | |
| Prepaid sponsorship | 25,231 | 21,754 | — | — | — | |
| Prepaid expenses and other current assets | 277,147 | 406,674 | — | — | — | |
| Total current assets | 7 | 6 | — | — | — | |
| Property and equipment, net | 277,377 | 454,268 | — | — | — | |
| Operating lease assets | 703,934 | 85,817 | — | — | — | |
| Deposits for facilities | 62,708 | 62,708 | — | — | — | |
| Intangible assets, net | 2 | 3 | — | — | — | |
| Investment in other securities, noncurrent | 700,000 | 700,000 | — | — | — | |
| Total other assets | 4 | 4 | — | — | — | |
| Total assets | 10 | 11 | — | — | — | |
| Accounts payable | 1 | 2 | — | — | — | |
| Accrued expenses | 735,672 | 632,674 | — | — | — | |
| Accrued dividends | 0 | 5 | — | — | — | |
| Deferred Revenue | 506,289 | 503,254 | — | — | — | |
| Operating leases current portion | 778,240 | 98,696 | — | — | — | |
| Convertible notes, at fair value | — | 1 | — | — | — | |
| Total current liabilities | 3 | 9 | — | — | — | |
| Operating leases - long term portion | 0 | 0 | — | — | — | |
| Total long term liabilities | 0 | 0 | — | — | — | |
| Total liabilities | 3 | 9 | — | — | — | |
| Commitments and Contingencies (Note 11) | — | — | — | — | — | |
| Preferred stock, authorized 50,000,000 shares, $0.001 par value, 1,700,000 and 5,000,000 shares issued and outstanding, respectively | 1,700 | 5,000 | — | — | — | |
| Common stock, authorized 150,000,000 shares, $0.001 par value, 8,917,054 and 492,383 shares issued and outstanding, respectively | 8,917 | 492 | — | — | — | |
| Additional paid in capital | 187 | 184 | — | — | — | |
| Comprehensive other expense | 0 | −7,189 | — | — | — | |
| Accumulated deficit | −179 | −182 | — | — | — | |
| Total cbdMD, Inc. shareholders' equity | 7 | 2 | 3 | 3 | 7 | |
| Total liabilities and shareholders' equity | 10 | 11 | — | — | — |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 | FY 2021 2021-09-30 |
|---|---|---|---|---|---|---|
| Stock based compensation | 0 | 5,015 | 233,666 | 555,215 | 1 | |
| Restricted stock expense | 14,121 | 11,885 | 109,202 | 373,610 | 2 | |
| Issuance of stock for services | 86,657 | 0 | — | 0 | 97,720 | |
| Inventory and materials impairment | 365,979 | 921,314 | 175,499 | 878,142 | 670,580 | |
| Intangibles amortization | 765,078 | 697,510 | 1 | 884,380 | 0 | |
| Depreciation | 361,063 | 452,326 | 404,280 | 948,962 | 1 | |
| Credit losses | 382,588 | 54,322 | — | — | — | |
| Gain on termination of operating lease | 0 | 696,280 | — | — | — | |
| Amortization of operating lease asset | 669,781 | 670,621 | 1 | 1 | 1 | |
| Accounts receivable | −439,565 | 177,858 | 278,482 | 65,541 | −183,735 | |
| Deposits | 0 | 76,000 | 105,898 | 284,977 | 261,125 | |
| Inventory | −732,919 | 766,472 | 27,443 | −112,189 | −1 | |
| Prepaid inventory | −55,789 | 23,670 | 328,784 | 40,060 | −263,341 | |
| Prepaid expenses and other current assets | 126,051 | 396,311 | 2 | −289,586 | 525,670 | |
| Accounts payable and accrued expenses | −261,883 | −1 | −1 | −2 | −104,422 | |
| Operating lease liability | −608,354 | −1 | −1 | −1 | −1 | |
| Deferred revenue / customer deposits | 3,099 | 318,008 | 203,341 | 203,341 | 3,723 | |
| Cash used by operating activities | −1 | −352,792 | −4 | −15 | −14 | |
| Purchase of intangible assets | 0 | −100,000 | 0 | 0 | −2 | |
| Purchase of property and equipment | −184,172 | −190,015 | −297,549 | −688,680 | −342,013 | |
| Cash used by investing activities | −184,172 | −290,015 | 702,451 | −688,680 | −3 | |
| Proceeds from issuance of common stock | 0 | 50,001 | 2 | 0 | 0 | |
| Note payable | 0 | 1 | −132,599 | −33,355 | −151,551 | |
| Proceeds from issuance of preferred stock | 1 | 0 | — | 0 | 31 | |
| Cash provided by financing activities | 1 | 1 | −1 | −4 | 28 | |
| Net (decrease) increase in cash | −191,311 | 654,693 | −5 | −20 | 12 | |
| Interest expense | — | 74,638 | 6,399 | 2,364 | 2,364 | |
| Issuance of shares for conversion of debt and accrued interest | 1 | 515,601 | 0 | — | — | |
| Change in lease asset related to extinguishment of HQ lease and new warehouse lease | −2 | 0 | — | — | — | |
| Issuance of shares for intangible asset | 0 | 40,725 | 0 | — | — | |
| Preferred dividends accrued but not paid | 2 | 4 | 667,000 | 0 | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro